In a wellness landscape crowded with generic solutions, Remedy's Nutrition® shifts the focus to individualized biological ...
Company expects preliminary unaudited AUCATZYL® net product revenue of approximately $24 million for the fourth quarter of 2025 and approximately ...
Two veterinarians suspended by HISA after track-office searches at Laurel and Delaware allegedly turn up banned substances ...
Ossium's approach fundamentally changes that paradigm by offering a high-quality, banked graft source that can be delivered within days rather than months. The published data highlight Ossium's ...
Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality ...